Influence of electroconvulsive therapy on white matter structure in a diffusion tensor imaging study.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 24 4 2019
medline: 13 4 2021
entrez: 24 4 2019
Statut: ppublish

Résumé

Electroconvulsive therapy (ECT) is a fast-acting intervention for major depressive disorder. Previous studies indicated neurotrophic effects following ECT that might contribute to changes in white matter brain structure. We investigated the influence of ECT in a non-randomized prospective study focusing on white matter changes over time. Twenty-nine severely depressed patients receiving ECT in addition to inpatient treatment, 69 severely depressed patients with inpatient treatment (NON-ECT) and 52 healthy controls (HC) took part in a non-randomized prospective study. Participants were scanned twice, approximately 6 weeks apart, using diffusion tensor imaging, applying tract-based spatial statistics. Additional correlational analyses were conducted in the ECT subsample to investigate the effects of seizure duration and therapeutic response. Mean diffusivity (MD) increased after ECT in the right hemisphere, which was an ECT-group-specific effect. Seizure duration was associated with decreased fractional anisotropy (FA) following ECT. Longitudinal changes in ECT were not associated with therapy response. However, within the ECT group only, baseline FA was positively and MD negatively associated with post-ECT symptomatology. Our data suggest that ECT changes white matter integrity, possibly reflecting increased permeability of the blood-brain barrier, resulting in disturbed communication of fibers. Further, baseline diffusion metrics were associated with therapy response. Coherent fiber structure could be a prerequisite for a generalized seizure and inhibitory brain signaling necessary to successfully inhibit increased seizure activity.

Sections du résumé

BACKGROUND
Electroconvulsive therapy (ECT) is a fast-acting intervention for major depressive disorder. Previous studies indicated neurotrophic effects following ECT that might contribute to changes in white matter brain structure. We investigated the influence of ECT in a non-randomized prospective study focusing on white matter changes over time.
METHODS
Twenty-nine severely depressed patients receiving ECT in addition to inpatient treatment, 69 severely depressed patients with inpatient treatment (NON-ECT) and 52 healthy controls (HC) took part in a non-randomized prospective study. Participants were scanned twice, approximately 6 weeks apart, using diffusion tensor imaging, applying tract-based spatial statistics. Additional correlational analyses were conducted in the ECT subsample to investigate the effects of seizure duration and therapeutic response.
RESULTS
Mean diffusivity (MD) increased after ECT in the right hemisphere, which was an ECT-group-specific effect. Seizure duration was associated with decreased fractional anisotropy (FA) following ECT. Longitudinal changes in ECT were not associated with therapy response. However, within the ECT group only, baseline FA was positively and MD negatively associated with post-ECT symptomatology.
CONCLUSION
Our data suggest that ECT changes white matter integrity, possibly reflecting increased permeability of the blood-brain barrier, resulting in disturbed communication of fibers. Further, baseline diffusion metrics were associated with therapy response. Coherent fiber structure could be a prerequisite for a generalized seizure and inhibitory brain signaling necessary to successfully inhibit increased seizure activity.

Identifiants

pubmed: 31010441
pii: S0033291719000758
doi: 10.1017/S0033291719000758
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

849-856

Auteurs

Jonathan Repple (J)

Department of Psychiatry, University of Muenster, Germany.

Susanne Meinert (S)

Department of Psychiatry, University of Muenster, Germany.

Irene Bollettini (I)

Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.

Dominik Grotegerd (D)

Department of Psychiatry, University of Muenster, Germany.

Ronny Redlich (R)

Department of Psychiatry, University of Muenster, Germany.

Dario Zaremba (D)

Department of Psychiatry, University of Muenster, Germany.

Christian Bürger (C)

Department of Psychiatry, University of Muenster, Germany.

Katharina Förster (K)

Department of Psychiatry, University of Muenster, Germany.

Katharina Dohm (K)

Department of Psychiatry, University of Muenster, Germany.

Felix Stahl (F)

Department of Psychiatry, University of Muenster, Germany.

Nils Opel (N)

Department of Psychiatry, University of Muenster, Germany.

Tim Hahn (T)

Department of Psychiatry, University of Muenster, Germany.

Verena Enneking (V)

Department of Psychiatry, University of Muenster, Germany.

Elisabeth J Leehr (EJ)

Department of Psychiatry, University of Muenster, Germany.

Joscha Böhnlein (J)

Department of Psychiatry, University of Muenster, Germany.

Ramona Leenings (R)

Department of Psychiatry, University of Muenster, Germany.

Claas Kaehler (C)

Department of Psychiatry, University of Muenster, Germany.
Institute of Pattern Recognition and Image Analysis, University of Muenster, Germany.

Daniel Emden (D)

Department of Psychiatry, University of Muenster, Germany.

Nils R Winter (NR)

Department of Psychiatry, University of Muenster, Germany.

Walter Heindel (W)

Department of Clinical Radiology, University of Muenster, Germany.

Harald Kugel (H)

Department of Clinical Radiology, University of Muenster, Germany.

Jochen Bauer (J)

Department of Clinical Radiology, University of Muenster, Germany.

Volker Arolt (V)

Department of Psychiatry, University of Muenster, Germany.

Francesco Benedetti (F)

Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.
University Vita-Salute San Raffaele, Italy.

Udo Dannlowski (U)

Department of Psychiatry, University of Muenster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH